0001062993-25-004986.txt : 20250307 0001062993-25-004986.hdr.sgml : 20250307 20250307174505 ACCESSION NUMBER: 0001062993-25-004986 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250305 FILED AS OF DATE: 20250307 DATE AS OF CHANGE: 20250307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marshall Robert J. Jr. CENTRAL INDEX KEY: 0001754976 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36569 FILM NUMBER: 25721452 MAIL ADDRESS: STREET 1: C/O LANTHEUS MEDICAL IMAGING, INC. STREET 2: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: MA ZIP: 01862 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lantheus Holdings, Inc. CENTRAL INDEX KEY: 0001521036 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 352318913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: MA ZIP: 01862 BUSINESS PHONE: 978 671-8001 MAIL ADDRESS: STREET 1: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: MA ZIP: 01862 FORMER COMPANY: FORMER CONFORMED NAME: Lantheus MI Holdings, Inc. DATE OF NAME CHANGE: 20110517 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2025-03-05 0001521036 Lantheus Holdings, Inc. LNTH 0001754976 Marshall Robert J. Jr. C/O LANTHEUS HOLDINGS, INC. 201 BURLINGTON ROAD, SOUTH BUILDING BEDFORD MA 01730 0 1 0 0 CFO and Treasurer 0 Common Stock 2025-03-05 4 A 0 23884 0 A 123860 D Stock Option (right to buy) 100.48 2025-03-05 4 A 0 13927 0 A 2035-03-05 Common Stock 13927 13927 D Consists of 7,961 restricted stock units that vest in equal installments over a three-year period and 15,923 Total Shareholder Return performance-based restricted stock units ("PSUs") that cliff vest following a three-year performance period. The amount of PSUs included in this Report reflects the target award; however, the ultimate award size can range from 0% to 200% of the target based on the actual performance achieved at the end of the performance period. The option vests in three equal annual installments beginning on March 5, 2026. /s/ Eric M. Green, attorney-in-fact 2025-03-07